This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (19)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Donor-Dominant Defect

Ross H. Daniel, MD; Winthrope R. Hubler, Jr, MD; John E. Wolf, Jr, MD; William R. Holder, MD

Arch Dermatol. 1977;113(1):53-56.

Abstract
• Histologic, pharmacologic, and exchange transplant studies were performed on a patient with nevus anemicus. Histologic examination disclosed no abnormalities. The only pharmacologic stimulus that produced erythema within the nevus was the -blocking agent, phentolamine mesylate. Results of the transplant studies demonstrated donor dominance. This suggests that the defect in the nevus anemicus is attributable to increased sensitivity of the blood vessels to catecholamines rather than to increased -adrenergic stimulation.

(Arch Dermatol 113:53-56, 1977)

Author Affiliations
From the Department of Dermatology, Baylor College of Medicine, Houston.

Footnotes
Accepted for publication Dec 1, 1975.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Loss of Cutaneous Delayed Hypersensitivity Reactions in Nevus Anemicus: Evidence for Close Concordance of Cutaneous Delayed Hypersensitivity and Endothelial E-selectin Expression
Mizutani et al.
Arch Dermatol 1997;133:617-620.
ABSTRACT  

Localized Cicatricial Pemphigoid (Brunsting-Perry) A Transplantation Experiment
Ahmed et al.
Arch Dermatol 1984;120:932-935.
ABSTRACT  

Nevus Oligemicus: A Variant of Nevus Anemicus
Davies et al.
Arch Dermatol 1981;117:111-113.
ABSTRACT